Loading the company…
Loading the company…
㈜나노젠
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2007. Industry: Cosmetics (K-Beauty). Revenue for 2025 was ₩22.7bn. It has 28 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Qualified”.
Loading…
Latest filing 2008-08-27 · latest registration 2011-06-28 · newest first
본 발명은 하이드로겐실리콘불소유도체(Trifluoropropyl Methylhydrogen Siloxane)을 이용하여 화장료용 안료를 표면코팅한 것으로 기존 안료의 문제점을 보완한 것이다. 본 발명의 안료 표면코팅 시스템은 반응성을 향상시켜 코팅의 안정성이 우수하며, 피부에 대하여 얇게 밀착되어 화장막이 얇고 깨끗하게 도포되도록 하게 하고, 내수성과 내유성을 동시에 향상시키어 땀이나 물에 얼룩이 지지 않아 화장의 지속성을 증가시킨다. 하이드로겐실리콘불소유도체, 표면코팅, 화장의 지속성, 깨끗한 화장, 색조화장료
본 발명은 바위솔(Orostachys Japonicus) 부처손(Selaginella Tamariscina) 인동덩굴(Lonicera Japonica Thunberg )및 청미래덩굴(Smilax China)의 혼합추출물을 함유하는 항염 및 항산화용 화장료 조성물을 제공한다. 본 발명의 화장료 조성물은 항염 및 항산화 효과를 갖는다. 바위솔, 부처손, 인동덩굴, 청미래덩굴, 항염, 항산화, 화장료
본 발명은 한련초(Eclipta prostrate)와 사상자(Cnidium Monnieri Fruit)의 혼합추출물을 함유하는 항염 및 피부자극 완화용 화장료 조성물을 제공한다. 본 발명의 화장료 조성물은 민감성 피부에 대하여 상승적인 항염 및 피부자극 완화 효과를 갖는다. 한련초, 사상자, 항염, 피부자극완화, 화장료
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 3 of 3 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 20.0 | 22.7 |
| Cost of sales | 17.1 | 19.7 |
| Gross profit (loss) | 2.9 | 3.0 |
| Selling, general and administrative expenses | 1.6 | 2.0 |
| Operating income (loss) | 1.3 | 1.0 |
| Non-operating income | 0.4 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.4 | 0.0 |
| Non-operating expenses | 0.0 | 0.2 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.0 | 0.2 |
| Other | — | 0.1 |
| Profit (loss) before tax | 1.6 | 0.9 |
| Income tax expense | 0.2 | 0.2 |
| Net income (loss) | 1.4 | 0.7 |
Revenue ₩22.7bn, up 13.4% YoY.
Operating margin 4.3% (prior 6.4%).
Net income ₩0.7bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06